Novavax, Inc. reported 3Q25 EPS loss & declining revenue, but beat revenue expectations & reaffirmed its FY25 guidance. Read ...

Press Release - Deal secures more accessible future price per dose, resulting savings of up to US$ 90 million Savings expected to help secure 30 million additional doses, protecting up to 7 million mo ...

Gavi, the Vaccine Alliance, and UNICEF have lowered the price of the new R21/Matrix-M malaria vaccine, a decision expected to expand access and protect close to seven million children across Africa ...

Gavi and UNICEF's new agreement aims to make malaria vaccines more affordable, saving $90 million and benefiting millions of children.

Gavi and UNICEF announce a new agreement to bulk procure the R21/Matrix-M malaria vaccine at a reduced price, aiming to save ...

Jefferies London Healthcare Conference 2025 November 19, 2025 11:30 AM ESTCompany ParticipantsRuxandra Draghia-Akli - Executive VP ...

FIFA approved two soccer players to change national eligibility to Congo from Belgium ahead of 2026 World Cup qualifying ...

With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported a loss of $202.4 million in its third quarter. On a per-share basis, the Gaithersburg, Maryland-based company ...

Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald initiated coverage of Novavax, Inc. (NASDAQ:NVAX) with an Overweight rating and a ...

Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. The Gaithersburg, Maryland-based ...